Indiana adding opioid treatment programs at five sites
The new sites are located at health centers in Johnson, Allen, Vigo, Monroe and Tippecanoe counties, the Indiana Family and Social Services Administration announced Wednesday morning.
Health Care
Articles
Pharmakon collected $560K in incentives before ceasing operations
Noblesville-based Pharmakon had a history of making state and local incentive agreements before suspending operations last year after a Food and Drug Administration investigation uncovered safety issues and possible criminal activity.
Trump nominates Indiana health commissioner for surgeon general
Dr. Jerome Adams was first appointed state health commissioner in October 2014 by then-Gov. Mike Pence. He has focused on issues such as the state’s opioid epidemic, high infant mortality rate and high rate of smoking.
Walgreens downsizes Rite Aid acquisition to 2,186 stores
Under the new agreement, Walgreens will buy 2,186 stores, three distribution centers and related inventory from Rite Aid for about $5.18 billion in cash.
Anthem’s exit creates Obamacare ‘crisis’ for rural Nevadans
The Indianapolis-based health insurer, a one-time Obamacare stalwart, has accelerated its retreat in recent weeks.
Pharmacy boss blamed for meningitis outbreak gets 9 years
The co-owner of a pharmacy responsible for the deaths of 76 people was sentenced Monday to nine years in prison. Indiana was one of the state hit hardest by the 2012 nationwide fungal meningitis outbreak.
Performance gap widening in some generic drugs, researchers say
As medicines—especially those that treat conditions such as anxiety or depression—are becoming more complex, it’s not just the mix of active ingredients that generic drugmakers have to replicate. It’s also the release mechanism.
Indiana crackdown on opioids sparks more pharmacy robberies
While making opioid prescriptions harder to get, Indiana’s crackdown helped spur a twofold increase in robberies of pharmacies that exacerbated the state’s standing as No. 1 in the nation for those crimes.
Lilly, Pfizer get boost for non-opioid pain drug
The companies say the drug, now in late-stage clinical trials, could be more effective for pain treatment than opioids—a dangerous category of pain killers that includes hydrocodone, morphine and fentanyl—without the abuse potential of such medications.
Only two insurers to offer Obamacare plans in Indiana next year
The Indiana Department of Insurance has yet to approve the insurers’ proposed higher rates, which will be for those buying individual plans on the Affordable Care Act marketplace next year.
Senate health plan relies on subsidies GOP has faulted
The proposal would provide an additional $50 billion over four years to stabilize insurance exchanges, relying on a mechanism Republicans have criticized in the past as a way to keep insurers in the marketplace.
Senate GOP plan expected to halt Obamacare penalties, taxes
Top Senate Republicans prepared Wednesday to release their plan for dismantling President Barack Obama’s health care law.
UPDATE: Anthem, MDwise pulling out of Indiana health insurance exchanges
Two Indianapolis-based health insurers are pulling out of Indiana’s insurance exchanges next year, citing growing uncertainty over the future of the Affordable Care Act. Together, they represent about 77,000 members who now must find other plans.
Nevada forces drugmakers to reveal insulin pricing, profits
America's three insulin manufacturers—Indianapolis-based Eli Lilly and Co., Sanofi and Novo Nordisk—would face fines of $5,000 daily if they fail to provide the data.
Worry rises over future of HIP 2.0 insurance program
Indiana hospitals are bracing for congressional action that could mean deep cuts in Medicaid, which funds the state’s popular health insurance program for low-income adults.
Drugmaker cashing in on opioid epidemic, one state law at a time
In statehouses across the country and in Congress, drugmaker Alkermes is pushing its own addiction treatment while contributing to misconceptions and stigma about other medications used to treat opioid addiction.
High court ruling speeds up generic biotech drug approval
The court's unanimous ruling Monday means a loss of billions in sales to makers of original versions of biologic drugs.
FDA asks drugmaker to stop selling its opioid painkiller
Besides contributing to overdoses, abuse of Opana ER was blamed for a 2015 outbreak of HIV and hepatitis C in southern Indiana linked to sharing needles, according to the FDA.
Anthem vows failed deal won’t derail growth plans
Just weeks after abandoning its proposed $48 billion merger with rival Cigna Corp., the Indianapolis-based health insurer is looking for its next deal. But this time, it is likely to be much smaller.
IU Health, competitors turn focus to improving experience for patients, families
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.